Akira Utsunomiya Noritaka Oyama Shiro Iino Natsuki Baba Takenao Chino Natsuko Utsunomiya Minoru Hasegawa
10.1159/000485910
Case Rep Dermatol
2018 Jan 18;10(1):1-6.
drug eruption erythema multiforme immune system ipilimumab nivolumab
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/29515387/
Case Reports
PMC5836162
29515387
A Case of Erythema Multiforme Major Developed after Sequential Use of Two Immune Checkpoint Inhibitors, Nivolumab and Ipilimumab, for Advanced Melanoma: Possible Implication of Synergistic and/or Complementary Immunomodulatory Effects
2018